Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients
Observational
OA: closed
CC0
⤵ 32 in-corpus citations
AI-generated summary
This study found increased serum levels of sTNFR-1 and angiogenin in endometriosis patients during the follicular phase, suggesting their potential as blood markers for the disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: Many soluble factors contributing to the pathophysiology of endometriosis are found at abnormal levels in patients suffering from the disease. We postulated that levels of these factors could also be altered in the serum of patients. We compared levels of insulin-like growth factor-1 (IGF-1), soluble form of tumor necrosis factor-alpha (TNF-alpha) receptor-1 (sTNFR-1) and angiogenin in the serum of patients with endometriosis and controls.
METHOD OF STUDY: Levels of IGF-1, sTNFR-1 and angiogenin were measured by enzyme-linked immunosorbent assay in samples from 148 patients (77 cases and 71 controls) with diagnostic confirmed by laparoscopy. Correlations with demographic data and stage of the disease were evaluated and potential confounders in the study population were controlled.
RESULTS: A significant increase in sTNFR-1 and angiogenin serum levels was observed in cases in comparison with controls, but only for patients in the follicular phase of the cycle. No significant difference was found in serum levels of IGF-1, sTNFR-1 and angiogenin between cases and controls in the luteal phase of the cycle. Correlations between levels of angiogenin and stage of the disease could also be observed.
CONCLUSION: sTNFR-1 and angiogenin represent potential blood markers for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (37)
- Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis via openalex
- Differential expression of IGF-I and IGF-II in eutopic and ectopic endometria of women with endometriosis and in women without endometriosis via openalex
- Epidemiology of endometriosis via openalex
- Increased concentrations of soluble tumour necrosis factor receptor (sTNFR) I and II in peritoneal fluid from women with endometriosis via openalex
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis via openalex
- Serum and peritoneal fluid levels of IGF I and II and insulinlike growth binding protein-3 in endometriosis via openalex
- Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines via openalex
- Theories of endometriosis via openalex
- Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- W2131971117 via openalex
- W2139455526 via openalex
- W2140656876 via openalex
- W2150571795 via openalex
- W2161018595 via openalex
- W2162275688 via openalex
- W2170197481 via openalex
- W2204640292 via openalex
- W2325290160 via openalex
- W4237742941 via openalex
- W101843882 via openalex
- W4290246058 via openalex
- W1567857738 via openalex
- W1573363574 via openalex
- W1607578883 via openalex
- W1985959551 via openalex
- W2017228357 via openalex
- W2052734866 via openalex
- W2063028898 via openalex
- W2065856353 via openalex
- W2072380594 via openalex
- W2073587114 via openalex
- W2107930829 via openalex
- W2121072799 via openalex
Cited by (33)
- Noninvasive diagnosis of external genital endometriosis based on the determination of cytokines controlling angiogenesis 2026
- Impaired bone morphogenetic protein (BMP) signaling pathways disrupt decidualization in endometriosis 2024
- Differential Expression of Insulin Growth Factor 1 (IGF-1) Isoforms in Different Types of Endometriosis: Preliminary Results of a Single-Center Study 2023
- Endometriosis biomarkers of the disease: an update 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls 2021
- Expression Levels of MCP-1, HGF, and IGF-1 in Endometriotic Patients Compared with Non-endometriotic Controls 2021
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives 2020
- The role of growth factors in the pathogenesis of endometriosis 2019
- Reduced inflammatory state promotes reinnervation of endometriotic-like lesions in TNFRp55 deficient mice 2019
- Biomarkers of endometriosis - current trends 2018
- Tumor Necrosis Factor and its Soluble Receptors as Potential Diagnostic Markers of Endometriosis 2017
- Epidemiological and Clinical Risk Factors for Endometriosis 2017
- Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Krüppel-Like Factor 13 Deficiency in Uterine Endometrial Cells Contributes to Defective Steroid Hormone Receptor Signaling but Not Lesion Establishment in a Mouse Model of Endometriosis 2015
- A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis 2015
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
- The emerging role of epigenetics in the aetiology of endometriosis. 2011
- Non-invasive diagnosis of endometriosis with proteomic technologies 2011
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2010
- Peripheral biomarkers of endometriosis: a systematic review 2010
- Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis 2010
- Decreased expression of angiogenin in the eutopic endometrium from women with advanced stage endometriosis 2008
- Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis 2008
- A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy 2006
- Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model 2006
- Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis 2005
- Serum adiponectin concentrations are decreased in women with endometriosis 2005
- Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis 2004
- Angiogenese und antiangiogene Therapien der Endometriose 2004
- Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome 2004
Source provenance
- europepmc
- last seen: 2026-10-11T06:14:19.339412+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:02:19.201584+00:00
- unpaywall
- last seen: 2026-10-11T06:28:45.473802+00:00
License: CC0
· commercial use OK